Envoy Medical, Inc., trading on Nasdaq under the ticker ANZU, is a Minnesota-based medical device company focused on hearing implant technology, including its fully implanted Acclaim cochlear implant system. The company went public through a business combination with Anzu Special Acquisition Corp I, a blank-check company sponsored by Anzu Partners LLC, which completed its IPO in 2021 and closed the de-SPAC merger in 2023. The December 3, 2025 Form 8-K filing reports a material corporate event in the post-merger operating phase of the combined company. Envoy Medical operates in the medical devices and healthcare technology sector. Visit SpacDesk and sign up for full data, filings history, and deal analytics on ANZU and hundreds of other SPAC transactions.